Margaret Pittman Lecture
Part of the Wednesday Afternoon Lecture Series, the lecture is given by a researcher dedicated to advancing and improving the careers of women scientists. Since 1994 when this annual lecture began, every speaker has exemplified the intelligence, scientific excellence and drive that made Margaret Pittman a leader as the first female laboratory chief at NIH.
Mutant p53 Activities in Mouse Tumor Models
The research in my lab has been focused on understanding the functional mechanism of cancer associated genes by generating mouse models. We have a long-standing interest in p53 gene as the most mutated gene in cancer. Mutation of the p53 gene is a critical event in the elaboration of many tumors of diverse origin. The p53 protein is activated in response to DNA damage, serving as a checkpoint in the elimination or repair of cells with damaged DNA.
Creating Healthy Longevity: A Basis for a Third Demographic Dividend for Society
Dr. Linda P. Fried, MD, MPH, is a global leader in the fields of epidemiology and geriatrics who has dedicated her career to the science of healthy aging and longer health span for all, and creating the knowledge needed for transition to a world where greater longevity benefits people of all ages. An internationally renowned scientist, she has authored over 500 peer-reviewed articles and chapters. Dr.
Peering Beyond the Blindspot Seeking Authentic Risk Factors: A Case Study
Eve Higginbotham, M.D., is professor of ophthalmology and vice dean for Inclusion and Diversity at the University of Pennsylvania. In her lecture, "Peering Beyond the Blindspot Seeking Authentic Risk Factors: A Case Study," she will discuss the arguments about "race" in the context of why this topic is important for its impact on care and care delivery. She will review a central corneal thickness case study and what the future may be for the discussion of risk factors.
A community approach to breast cancer prevention: addressing health disparities
Dr. Adams-Campbell's areas of research focus on addressing health disparities with particular emphasis on cancers that disproportionately impact African-Americans. Dr. Adams-Campbell's research focuses on lifestyle interventions including physical activity, energy balance, obesity, metabolic syndrome, and oral health among minority and underserved populations.
Cerebellar synaptic signaling as a metaphor for mentorship: how silence and speech get different deeds done
The cerebellum facilitates learned, coordinated movements and corrects errors. Signals to execute these functions are carried by the large neurons of the cerebellar nuclei, which form the major premotor projection from the cerebellum.
Unraveling Smell
Dr. Linda Buck is a Howard Hughes Medical Institute Investigator, a Full Member of Fred Hutchinson Cancer Research Center, and an Affiliate Professor at the University of Washington. She received a B.S. from the University of Washington and a Ph.D. from the University of Texas Southwestern Medical Center. She was previously Full Professor of Neurobiology at Harvard Medical School. Dr.
Tailored drug release surfaces for regenerative medicine and targeted nanotherapies
Alternating electrostatic assembly is a tool that makes it possible to create ultrathin film coatings that contain highly controlled quantities of one or more therapeutic molecules within a singular construct. These release systems greatly exceed the usual ranges of traditional degradable polymers. The nature of the layering process enables the incorporation of different drugs within different regions of the thin-film architecture; the result is an ability to uniquely tailor both the independent-release profiles and order-of-release of each therapeutic to the targeted region of the body.
CRISPR-Cas Genome Surveillance: From Basic Biology to Transformative Technology
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. Dr. Doudna will present a brief history of CRISPR biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, providing the foundation for remarkable developments using this technology to modify, regulate or mark genomic loci in a wide variety of cells and organisms.
Did you remember to take out the trash? Your cells sure did!
Autophagy is an essential catabolic cellular process that assures the maintenance of the cellular energetic balance as wells as an efficient removal of any intracellular damaged structure. In this talk, Dr. Cuervo will focus on selective forms of autophagy, and describe her lab’s recent advances on the identification of new molecular effectors and regulators for these pathways, the physiological role, and their changes in aging and age-related metabolic disorders and neurodegenerative diseases such as Parkinson, Alzheimer and Huntington disease.
The page was last updated on Thursday, January 29, 2015 - 2:29pm
